Fertility preservation outcomes may differ by cancer diagnosis
Context : Cancer survival has improved significantly and maintaining fertility is both a major concern and an important factor for the quality of life in cancer patients. Aims : To explore differences in oocyte stimulation for fertility preservation (FP) patients based on cancer diagnosis. Settings...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2014-01-01
|
Series: | Journal of Human Reproductive Sciences |
Subjects: | |
Online Access: | http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2014;volume=7;issue=2;spage=111;epage=118;aulast=Pavone |
id |
doaj-ae6b86ee18564ed9a0b1f324e6c150d1 |
---|---|
record_format |
Article |
spelling |
doaj-ae6b86ee18564ed9a0b1f324e6c150d12020-11-24T23:35:24ZengWolters Kluwer Medknow PublicationsJournal of Human Reproductive Sciences0974-12081998-47662014-01-017211111810.4103/0974-1208.138869Fertility preservation outcomes may differ by cancer diagnosisMary Ellen PavoneJennifer Hirshfeld-CytronAngela K LawsonKristin SmithRalph KazerSusan KlockContext : Cancer survival has improved significantly and maintaining fertility is both a major concern and an important factor for the quality of life in cancer patients. Aims : To explore differences in oocyte stimulation for fertility preservation (FP) patients based on cancer diagnosis. Settings and Deign : Between 2005 and 2011, 109 patients elected to pursue FP at a single institution. Materials and Method : In vitro fertilization (IVF) outcome variables between four cancer diagnostic groups (breast, gynecologic, lymphoma/leukemia and other) and age-matched male factor or tubal factor infertility IVF control group were compared. Statistical Analysis : ANOVA and Chi-square analyses were employed to compare variables between the groups that were normally distributed. Kruskal-Wallis with subsequent Mann-Whitney U-test were used for data that were not normally distributed. Results : Women with gynecologic malignancies were significantly older than the women in the other three groups, but tended to have a better ovarian response. Women with hematologic malignancies were most likely to have been exposed to chemotherapy and had the longest stimulations with a similar number of oocytes retrieved. The age-matched IVF controls had higher peak estradiol levels, number of oocytes obtained, and fertilization rates when compared to cancer patients with or without a history of prior chemotherapy. Conclusions : Factors including age, type of cancer and chemotherapy exposure, can influence response to ovarian stimulation. Discussing these findings with patients presenting for FP may aid in setting realistic treatment expectations.http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2014;volume=7;issue=2;spage=111;epage=118;aulast=PavoneCancercryopreservationfertility preservationin vitro fertilizationoncofertility |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mary Ellen Pavone Jennifer Hirshfeld-Cytron Angela K Lawson Kristin Smith Ralph Kazer Susan Klock |
spellingShingle |
Mary Ellen Pavone Jennifer Hirshfeld-Cytron Angela K Lawson Kristin Smith Ralph Kazer Susan Klock Fertility preservation outcomes may differ by cancer diagnosis Journal of Human Reproductive Sciences Cancer cryopreservation fertility preservation in vitro fertilization oncofertility |
author_facet |
Mary Ellen Pavone Jennifer Hirshfeld-Cytron Angela K Lawson Kristin Smith Ralph Kazer Susan Klock |
author_sort |
Mary Ellen Pavone |
title |
Fertility preservation outcomes may differ by cancer diagnosis |
title_short |
Fertility preservation outcomes may differ by cancer diagnosis |
title_full |
Fertility preservation outcomes may differ by cancer diagnosis |
title_fullStr |
Fertility preservation outcomes may differ by cancer diagnosis |
title_full_unstemmed |
Fertility preservation outcomes may differ by cancer diagnosis |
title_sort |
fertility preservation outcomes may differ by cancer diagnosis |
publisher |
Wolters Kluwer Medknow Publications |
series |
Journal of Human Reproductive Sciences |
issn |
0974-1208 1998-4766 |
publishDate |
2014-01-01 |
description |
Context : Cancer survival has improved significantly and maintaining fertility is both a major concern and an important factor for the quality of life in cancer patients. Aims : To explore differences in oocyte stimulation for fertility preservation (FP) patients based on cancer diagnosis. Settings and Deign : Between 2005 and 2011, 109 patients elected to pursue FP at a single institution. Materials and Method : In vitro fertilization (IVF) outcome variables between four cancer diagnostic groups (breast, gynecologic, lymphoma/leukemia and other) and age-matched male factor or tubal factor infertility IVF control group were compared. Statistical Analysis : ANOVA and Chi-square analyses were employed to compare variables between the groups that were normally distributed. Kruskal-Wallis with subsequent Mann-Whitney U-test were used for data that were not normally distributed. Results : Women with gynecologic malignancies were significantly older than the women in the other three groups, but tended to have a better ovarian response. Women with hematologic malignancies were most likely to have been exposed to chemotherapy and had the longest stimulations with a similar number of oocytes retrieved. The age-matched IVF controls had higher peak estradiol levels, number of oocytes obtained, and fertilization rates when compared to cancer patients with or without a history of prior chemotherapy. Conclusions : Factors including age, type of cancer and chemotherapy exposure, can influence response to ovarian stimulation. Discussing these findings with patients presenting for FP may aid in setting realistic treatment expectations. |
topic |
Cancer cryopreservation fertility preservation in vitro fertilization oncofertility |
url |
http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2014;volume=7;issue=2;spage=111;epage=118;aulast=Pavone |
work_keys_str_mv |
AT maryellenpavone fertilitypreservationoutcomesmaydifferbycancerdiagnosis AT jenniferhirshfeldcytron fertilitypreservationoutcomesmaydifferbycancerdiagnosis AT angelaklawson fertilitypreservationoutcomesmaydifferbycancerdiagnosis AT kristinsmith fertilitypreservationoutcomesmaydifferbycancerdiagnosis AT ralphkazer fertilitypreservationoutcomesmaydifferbycancerdiagnosis AT susanklock fertilitypreservationoutcomesmaydifferbycancerdiagnosis |
_version_ |
1725526324435484672 |